ATE435290T1 - Glycosyltransferasen für die biosynthese von oligosacchariden und dafür kodierende gene - Google Patents

Glycosyltransferasen für die biosynthese von oligosacchariden und dafür kodierende gene

Info

Publication number
ATE435290T1
ATE435290T1 AT95934548T AT95934548T ATE435290T1 AT E435290 T1 ATE435290 T1 AT E435290T1 AT 95934548 T AT95934548 T AT 95934548T AT 95934548 T AT95934548 T AT 95934548T AT E435290 T1 ATE435290 T1 AT E435290T1
Authority
AT
Austria
Prior art keywords
beta
glycosyltransferases
oligosaccharides
mimic
biosynthesis
Prior art date
Application number
AT95934548T
Other languages
English (en)
Inventor
Emil Gotschlich
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Application granted granted Critical
Publication of ATE435290T1 publication Critical patent/ATE435290T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT95934548T 1994-09-26 1995-09-25 Glycosyltransferasen für die biosynthese von oligosacchariden und dafür kodierende gene ATE435290T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/312,387 US5545553A (en) 1994-09-26 1994-09-26 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
PCT/US1995/012317 WO1996010086A1 (en) 1994-09-26 1995-09-25 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them

Publications (1)

Publication Number Publication Date
ATE435290T1 true ATE435290T1 (de) 2009-07-15

Family

ID=23211210

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95934548T ATE435290T1 (de) 1994-09-26 1995-09-25 Glycosyltransferasen für die biosynthese von oligosacchariden und dafür kodierende gene
AT05076067T ATE513916T1 (de) 1994-09-26 1995-09-25 Deletionsmutante von neisseria glycosyltransferase für die oligosaccharidebiosynthese, und deren gene

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05076067T ATE513916T1 (de) 1994-09-26 1995-09-25 Deletionsmutante von neisseria glycosyltransferase für die oligosaccharidebiosynthese, und deren gene

Country Status (10)

Country Link
US (9) US5545553A (de)
EP (2) EP0784688B1 (de)
JP (2) JP3756182B2 (de)
KR (1) KR100465892B1 (de)
AT (2) ATE435290T1 (de)
CA (2) CA2200973A1 (de)
DE (1) DE69535975D1 (de)
ES (1) ES2371440T3 (de)
MX (1) MX9702351A (de)
WO (1) WO1996010086A1 (de)

Families Citing this family (179)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785988A1 (de) 1993-07-15 1997-07-30 Neose Pharmaceuticals, Inc Verfahren zur synthese von saccharidzusammensetzungen
US6495348B1 (en) * 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
US6524812B1 (en) 1993-10-07 2003-02-25 Regents Of The University Of Minnesota Genes encoding resistance to DNA alkylating agents
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US6127153A (en) * 1995-06-07 2000-10-03 Neose Technologies, Inc. Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase
WO1997022711A1 (en) 1995-12-19 1997-06-26 Regents Of The University Of Minnesota Metabolic engineering of polyhydroxyalkanoate monomer synthases
US6096529A (en) * 1996-06-10 2000-08-01 National Research Council Of Canada Recombinant α-2,3-sialyltransferases and their uses
ATE386126T1 (de) * 1996-11-08 2008-03-15 Neose Technologies Inc Verbesserte expressionsvektoren
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US5945314A (en) * 1997-03-31 1999-08-31 Abbott Laboratories Process for synthesizing oligosaccharides
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6075183A (en) * 1997-04-11 2000-06-13 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US6051754A (en) * 1997-04-11 2000-04-18 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US5972664A (en) * 1997-04-11 1999-10-26 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US7745694B1 (en) 1997-04-11 2010-06-29 Monsanto Technology Llc Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
US5968809A (en) 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US6096725A (en) * 1997-07-02 2000-08-01 Neose Technologies, Inc. Methods of using αGal oligosaccharides as immune system targeting agents
JPH11221079A (ja) 1998-02-04 1999-08-17 Kyowa Hakko Kogyo Co Ltd 糖転移酵素および該酵素をコードするｄｎａ
US6689604B1 (en) * 1998-03-20 2004-02-10 National Research Council Of Canada Lipopolysaccharide α-2,3 sialyltransferase of Campylobacter jejuni and its uses
AU759792B2 (en) 1998-03-25 2003-05-01 Forschungszentrum Borstel Processive glycosyltransferase
DK1086236T3 (da) 1998-06-12 2007-12-03 Calgene Llc Polyumættede fedtsyrer i planter
US6265202B1 (en) 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
FR2780413B1 (fr) * 1998-06-29 2003-03-21 Centre Nat Rech Scient Enzymes a activite alpha-galactosyltransferase de cellules d'insectes, et leurs utilisations
US6897052B1 (en) * 1998-08-07 2005-05-24 Glycodesign Holdings Ltd. N-acetylglycosaminyl transferase genes
WO2000012747A1 (en) * 1998-08-31 2000-03-09 Kurt Nilsson Method for enzymatic synthesis of glycosides, disaccharides, and oligosaccharides
US6403349B1 (en) 1998-09-02 2002-06-11 Abbott Laboratories Elongase gene and uses thereof
US20030163845A1 (en) * 1998-09-02 2003-08-28 Pradip Mukerji Elongase genes and uses thereof
EP1131415A4 (de) * 1998-11-18 2002-09-11 Neose Technologies Inc Kostengünstige herstellung von oligosacchariden
US7820393B2 (en) 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) * 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US6503744B1 (en) 1999-02-01 2003-01-07 National Research Council Of Canada Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
US6699705B2 (en) * 1999-02-01 2004-03-02 National Research Council Of Canada Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
CA2374235A1 (en) * 1999-05-18 2000-11-23 University Of Iowa Research Foundation Production of complex carbohydrates
FR2796082B1 (fr) * 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
US7070970B2 (en) 1999-08-23 2006-07-04 Abbott Laboratories Elongase genes and uses thereof
AUPQ275799A0 (en) * 1999-09-10 1999-10-07 Luminis Pty Limited Recombinant bacterium expressing an oligosaccharide receptor mimic
US6518037B2 (en) * 1999-11-12 2003-02-11 University Of Iowa Research Foundation Two-component system that controls bacterial membrane synthesis
WO2001059079A1 (en) * 2000-02-11 2001-08-16 Glycozym Aps UDP-GALACTOSE: β-D-GALACTOSE-R 4-α-D-GALACTOSYLTRANSFERASE, α4GAL-T1
US7449308B2 (en) 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
US7863020B2 (en) * 2000-06-28 2011-01-04 Glycofi, Inc. Production of sialylated N-glycans in lower eukaryotes
US7598055B2 (en) * 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
US7625756B2 (en) * 2000-06-28 2009-12-01 GycoFi, Inc. Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
US8697394B2 (en) * 2000-06-28 2014-04-15 Glycofi, Inc. Production of modified glycoproteins having multiple antennary structures
ATE440959T1 (de) 2000-06-28 2009-09-15 Glycofi Inc Verfahren für die herstellung modifizierter glykoproteine
US20030194784A1 (en) * 2001-04-17 2003-10-16 Sherman David H. DNA encoding methymycin and pikromycin
JP2005500058A (ja) 2001-08-17 2005-01-06 ネオーズ テクノロジーズ， インコーポレイテッド シアリル化したオリゴサッカリドの化学的酵素的合成
WO2003025133A2 (en) * 2001-09-14 2003-03-27 Mimeon, Inc. Methods of making glycolmolecules with enhanced activities and uses thereof
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
EP2042196B1 (de) 2001-10-10 2016-07-13 ratiopharm GmbH Neumodellierung und Glykokonjugation von Granulozyten-Kolonie stimulierender Faktor (G-CSF)
US7399613B2 (en) * 2001-10-10 2008-07-15 Neose Technologies, Inc. Sialic acid nucleotide sugars
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7125843B2 (en) * 2001-10-19 2006-10-24 Neose Technologies, Inc. Glycoconjugates including more than one peptide
US8008252B2 (en) * 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7297511B2 (en) * 2001-10-10 2007-11-20 Neose Technologies, Inc. Interferon alpha: remodeling and glycoconjugation of interferon alpha
US7265084B2 (en) * 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7157277B2 (en) * 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7696163B2 (en) 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
US7179617B2 (en) 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
US7226903B2 (en) * 2001-10-10 2007-06-05 Neose Technologies, Inc. Interferon beta: remodeling and glycoconjugation of interferon beta
US7265085B2 (en) * 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycoconjugation methods and proteins/peptides produced by the methods
US7439043B2 (en) * 2001-10-10 2008-10-21 Neose Technologies, Inc. Galactosyl nucleotide sugars
US7473680B2 (en) * 2001-11-28 2009-01-06 Neose Technologies, Inc. Remodeling and glycoconjugation of peptides
MXPA04012496A (es) 2002-06-21 2005-09-12 Novo Nordisk Healthcare Ag Glicoformos del factor vii pegilados.
CA2493124C (en) 2002-08-02 2014-04-29 Glaxosmithkline Biologicals S.A. Vaccine
US7332299B2 (en) 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes
WO2004080960A2 (en) 2003-03-06 2004-09-23 Neose Technologies Inc. Methods and compositions for the enzymatic synthesis of gangliosides
JP2006523211A (ja) 2003-03-14 2006-10-12 ネオス テクノロジーズ インコーポレイテッド 分岐水溶性ポリマーとその複合物
WO2007022512A2 (en) * 2005-08-19 2007-02-22 Neose Technologies, Inc. Glycopegylated factor vii and factor viia
NZ542586A (en) 2003-04-09 2009-11-27 Biogenerix Ag Method of forming a covalent conjugate between a G-CSF peptide and PEG
EP1613261A4 (de) * 2003-04-09 2011-01-26 Novo Nordisk As Intrazelluläre bildung von peptidkonjugaten
WO2006127896A2 (en) * 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated factor ix
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
AU2004240553A1 (en) 2003-05-09 2004-12-02 Neose Technologies, Inc. Compositions and methods for the preparation of human growth hormone glycosylation mutants
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
ATE430802T1 (de) 2003-08-21 2009-05-15 Monsanto Technology Llc Fettsäuredesaturasen aus primula
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US7405198B2 (en) * 2003-11-24 2008-07-29 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
WO2005055946A2 (en) * 2003-12-03 2005-06-23 Neose Technologies, Inc. Glycopegylated granulocyte colony stimulating factor
US20060040856A1 (en) * 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
US7956032B2 (en) * 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US20080318850A1 (en) * 2003-12-03 2008-12-25 Neose Technologies, Inc. Glycopegylated Factor Ix
EP2497478A3 (de) 2003-12-05 2012-11-07 Children's Hospital Medical Center Oligosaccarid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen
US7338933B2 (en) 2004-01-08 2008-03-04 Neose Technologies, Inc. O-linked glycosylation of peptides
NZ548893A (en) 2004-02-04 2009-09-25 Biogernerix Ag Methods of refolding mammalian glycosyltransferases
CN1968688A (zh) 2004-04-16 2007-05-23 孟山都技术有限公司 脂肪酸去饱和酶在玉米中的表达
KR20070008645A (ko) 2004-05-04 2007-01-17 노보 노르디스크 헬스 케어 악티엔게젤샤프트 폴리펩티드의 ｏ-연결된 단백당형 및 그들의 제조 방법
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
US20090292110A1 (en) * 2004-07-23 2009-11-26 Defrees Shawn Enzymatic modification of glycopeptides
EP1799249A2 (de) 2004-09-10 2007-06-27 Neose Technologies, Inc. Glycopegyliertes interferon alpha
EP1797192A1 (de) * 2004-09-29 2007-06-20 Novo Nordisk Health Care AG Modifizierte proteine
EP3061461A1 (de) 2004-10-29 2016-08-31 ratiopharm GmbH Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
JP2008526864A (ja) * 2005-01-06 2008-07-24 ネオス テクノロジーズ インコーポレイテッド 糖断片を用いる糖結合
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
EP1866427A4 (de) * 2005-03-30 2010-09-01 Novo Nordisk As Herstellungsverfahren zur produktion von in insektenzelllinien entstandenen peptiden
EP1871795A4 (de) * 2005-04-08 2010-03-31 Biogenerix Ag Zusammensetzungen und verfahren zur herstellung von glycosylierungsmutanten eines proteaseresistenten menschlichen wachstumshormons
US20110003744A1 (en) * 2005-05-25 2011-01-06 Novo Nordisk A/S Glycopegylated Erythropoietin Formulations
WO2006127910A2 (en) 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated erythropoietin formulations
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) * 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
DE602007003596D1 (de) 2006-06-12 2010-01-14 Glaxosmithkline Biolog Sa Impfstoff
MX2009000757A (es) 2006-07-19 2009-03-09 Monsanto Technology Llc Acido graso desaturasas de tetraselmis suecica.
US20080242607A1 (en) * 2006-07-21 2008-10-02 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
BRPI0717505B8 (pt) 2006-10-04 2021-05-25 Novo Nordisk As conjugado de peptídeo e formulação farmacêutica
US20080207487A1 (en) * 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
CN101796063B (zh) 2007-04-03 2017-03-22 拉蒂奥法姆有限责任公司 使用糖聚乙二醇化g‑csf的治疗方法
US20090053167A1 (en) * 2007-05-14 2009-02-26 Neose Technologies, Inc. C-, S- and N-glycosylation of peptides
US20110177029A1 (en) * 2007-06-04 2011-07-21 Novo Nordisk A/S O-linked glycosylation using n-acetylglucosaminyl transferases
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
US7968811B2 (en) * 2007-06-29 2011-06-28 Harley-Davidson Motor Company Group, Inc. Integrated ignition and key switch
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
JP5647899B2 (ja) * 2008-01-08 2015-01-07 ラツィオファルム ゲーエムベーハーｒａｔｉｏｐｈａｒｍ ＧｍｂＨ オリゴサッカリルトランスフェラーゼを使用するポリペプチドの複合糖質化
DK2257311T3 (da) 2008-02-27 2014-06-30 Novo Nordisk As Konjugerede Faktor VIII-Molekyler
EP2418961B1 (de) 2009-04-13 2017-12-13 Instituto Nacional De Ciencias Medicas Y Nutricion Milch-oligosaccharid-zusammensetzung und ihre verwendung bei der behandlung von infektionen bei tieren
JP2012532195A (ja) 2009-07-06 2012-12-13 チルドレンズ ホスピタル メディカル センター 乳オリゴ糖による炎症の阻害
CA2794697A1 (en) 2010-04-07 2011-10-13 Momenta Pharmaceuticals, Inc. High mannose glycans
EP2465508A1 (de) 2010-11-23 2012-06-20 Nestec S.A. Zusammensetzung mit hydrolysierten Proteinen und Oligosacchariden zur Behandlung von Hautkrankheiten
EP2454948A1 (de) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharidmischung und Lebensmittel mit dieser Mischung, insbesondere Säuglingsnahrung
EP2465509A1 (de) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharid Zusammensetzung zur Behandlung von akuten Atemwegsinfektionen
EP2465507A1 (de) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharid Zusammensetzung zur Behandlung von Hautkrankheiten
ES2556985T3 (es) 2011-01-11 2016-01-21 Capsugel Belgium Nv Nuevas cápsulas duras que comprenden pululano
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
ES2559381T3 (es) 2011-10-18 2016-02-11 Nestec S.A. Composición para su uso en la promoción del crecimiento de hueso sano y/o en la prevención y/o tratamiento de osteopatía
US9636367B2 (en) 2011-10-18 2017-05-02 Nestec S.A. Composition for use in increasing insulin sensitivity and/or reducing insulin resistance
WO2013057049A1 (en) 2011-10-18 2013-04-25 Nestec S.A. Composition for use in brain growth and/or cognitive and/or psychomotor development
CN103889239A (zh) 2011-10-18 2014-06-25 雀巢产品技术援助有限公司 用于促进肠血管生成和营养吸收和经肠喂养耐受性和/或预防和/或治疗肠炎、和/或肠损伤和手术后恢复的组合物
WO2013057072A1 (en) 2011-10-18 2013-04-25 Nestec S.A. Composition for use in the promotion of magnesium absorption and/or magnesium retention
EP2856159A4 (de) 2012-06-01 2016-04-13 Momenta Pharmaceuticals Inc Verfahren im zusammenhang mit denosumab
EP2877589B1 (de) 2012-07-26 2024-03-06 Momenta Pharmaceuticals, Inc. Glykoproteine mit entzündungshemmenden eigenschaften
TWI563092B (en) * 2012-08-20 2016-12-21 Academia Sinica Large scale enzymatic synthesis of oligosaccharides
EP2855533A4 (de) 2013-03-15 2015-11-25 Momenta Pharmaceuticals Inc Verfahren in zusammenhang mit ctla4-fc-fusionsproteinen
US10464996B2 (en) 2013-05-13 2019-11-05 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
AU2014350157A1 (en) 2013-11-15 2016-04-14 Nestec S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
CN105722514A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗剖腹产婴儿或幼儿的坏死性小肠结肠炎的组合物
CN105722515A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
RU2731154C2 (ru) 2015-03-05 2020-08-31 Сосьете Де Продюи Нестле С.А. Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста
CN114532538A (zh) 2015-03-05 2022-05-27 雀巢产品有限公司 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
MX378680B (es) 2015-03-05 2025-03-11 Soc Des Produits Nestle S A Star Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
WO2016176484A1 (en) 2015-04-28 2016-11-03 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US20190160082A1 (en) 2016-08-04 2019-05-30 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis
EP4477262A3 (de) 2016-09-07 2025-04-23 Société des Produits Nestlé S.A. Nährstoffzusammensetzungen für säuglinge und/oder kleinkinder
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CA3059527A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Pullulan capsules
WO2018189587A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Process for making pullulan
EP4382108A3 (de) 2017-05-09 2024-08-28 Société des Produits Nestlé S.A. Synergistische herstellung von butyrat im zusammenhang mit der komplexität einer hmos-mischung zur verwendung bei säuglingen oder kleinkindern für gesundheitszwecke
WO2018215572A1 (en) 2017-05-24 2018-11-29 Nestec S.A. Composition comprising human milk oligosaccharides (hmo) for use in the improvement of short term memory and other cognitive benefits
CN110769703A (zh) 2017-05-24 2020-02-07 雀巢产品有限公司 用于改善短期记忆和其他认知益处的包含低聚果糖(of)的组合物
PH12019550208B1 (en) 2017-05-24 2024-05-24 Socia‰Ta‰ Des Produits Nestla‰ S A Hmos blends for use in infants or young children for health purposes
AU2018387279B2 (en) 2017-12-21 2024-10-24 Societe Des Produits Nestle S.A. Compositions comprising at least one N-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
ES3055329T3 (en) 2017-12-21 2026-02-11 Nestle Sa Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motility
CN111432661A (zh) 2017-12-22 2020-07-17 雀巢产品有限公司 用途是用于减少婴儿和幼儿的伤害感觉的组合物
WO2020001862A1 (en) 2018-06-25 2020-01-02 Societe Des Produits Nestle S.A. Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
EP3809879A1 (de) 2018-06-25 2021-04-28 Société des Produits Nestlé S.A. Zusammensetzung mit menschlichen milcholigosacchariden zur verwendung bei der verbesserung, verstärkung, förderung oder modulation einer gabaergen funktion im zentralnervensystem
EP3650044A1 (de) * 2018-11-06 2020-05-13 ETH Zürich Anti-glykan-impfstoffe
MX2021005668A (es) 2018-11-30 2021-06-15 Nestle Sa Composicion nutricional infantil para usar en el mejoramiento de la maduracion pancreatica y la biosintesis de insulina.
EP3897208B1 (de) 2018-12-21 2025-02-26 Société des Produits Nestlé S.A. Ernährungszusammensetzung enthaltend eine kombination von humanmilch-oligosacchariden zur verbesserung der magen-darm-barriere
US12167742B2 (en) 2018-12-21 2024-12-17 Societe Des Produits Nestle S.A. Nutritional composition comprising 6′SL and LNT in combination to improve the gastrointestinal barrier function
AU2019407214B2 (en) 2018-12-21 2025-04-24 Societe Des Produits Nestle S.A. A nutritional composition comprising metabolites of HMOs to improve the gastrointestinal barrier
US20220225627A1 (en) 2019-03-05 2022-07-21 Societe Des Produits Nestle S.A. A nutritional composition for use to enhance executive function
JP2022541757A (ja) * 2019-07-08 2022-09-27 クラポード バイオ，インコーポレイテッド リポオリゴ糖組成物およびワクチンの製造および使用方法
CA3153046A1 (en) 2019-10-17 2021-04-22 Societe Des Produits Nestle S.A. Infant formula
WO2021074374A1 (en) 2019-10-17 2021-04-22 Société des Produits Nestlé S.A. Extensively hydrolysed infant formula
AU2020399200A1 (en) 2019-12-11 2022-06-09 Société des Produits Nestlé S.A. Compositions for use in the reduction of nociception and other health benefits in infants and young children
BR112022010083A2 (pt) 2019-12-30 2022-09-06 Nestle Sa Fórmula para bebês
AU2021359711A1 (en) 2020-10-16 2023-03-23 Société des Produits Nestlé S. A. Nutritional composition comprising human milk oligosaccharides
CA3192821A1 (en) 2020-10-16 2022-04-21 Societe Des Produits Nestle S.A. Infant or young child formula
JP2023547175A (ja) 2020-11-10 2023-11-09 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 栄養組成物
WO2022129556A1 (en) 2020-12-18 2022-06-23 Société des Produits Nestlé S.A. Compositions for use in promoting accelerated butyrate production in young children
CN117915787A (zh) 2021-06-29 2024-04-19 博德研究所有限公司 长双歧杆菌过渡型微生物、其组合物及其用途
WO2023034973A1 (en) * 2021-09-02 2023-03-09 Amyris, Inc. Methods of producing human milk oligosaccharides and compositions thereof
CN119300839A (zh) 2022-06-09 2025-01-10 雀巢产品有限公司 包含gos和hmo的营养组合物
WO2024235730A2 (en) 2023-05-16 2024-11-21 Société des Produits Nestlé S.A. Nutritional composition
CN121419685A (zh) 2023-07-06 2026-01-27 雀巢产品有限公司 用于肠道健康的饮食管理的组合

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1479268A (en) * 1973-07-05 1977-07-13 Beecham Group Ltd Pharmaceutical compositions
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
CH596313A5 (de) * 1975-05-30 1978-03-15 Battelle Memorial Institute
US4385260A (en) * 1975-09-09 1983-05-24 Beckman Instruments, Inc. Bargraph display
US4414147A (en) * 1981-04-17 1983-11-08 Massachusetts Institute Of Technology Methods of decreasing the hydrophobicity of fibroblast and other interferons
JPS57206622A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Blood substitute
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4565653A (en) * 1984-03-30 1986-01-21 Pfizer Inc. Acyltripeptide immunostimulants
US4879236A (en) * 1984-05-16 1989-11-07 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
JPS6238172A (ja) * 1985-08-12 1987-02-19 株式会社　高研 抗血栓性医用材料の製造方法
US4767702A (en) * 1986-02-06 1988-08-30 Cohenford Menashi A Paper strip assay for neisseria species
US4925796A (en) * 1986-03-07 1990-05-15 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
US5153265A (en) * 1988-01-20 1992-10-06 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
GB8810808D0 (en) * 1988-05-06 1988-06-08 Wellcome Found Vectors
US5169933A (en) * 1988-08-15 1992-12-08 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
US5874261A (en) * 1988-09-02 1999-02-23 The Trustees Of The University Of Pennsylvania Method for the purification of glycosyltransferases
US6166183A (en) * 1992-11-30 2000-12-26 Kirin-Amgen, Inc. Chemically-modified G-CSF
US5194376A (en) * 1989-02-28 1993-03-16 University Of Ottawa Baculovirus expression system capable of producing foreign gene proteins at high levels
US5527527A (en) * 1989-09-07 1996-06-18 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
US5977307A (en) * 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
US5182107A (en) * 1989-09-07 1993-01-26 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
US5672683A (en) * 1989-09-07 1997-09-30 Alkermes, Inc. Transferrin neuropharmaceutical agent fusion protein
US5154924A (en) * 1989-09-07 1992-10-13 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
DE4009630C2 (de) * 1990-03-26 1995-09-28 Reinhard Prof Dr Dr Brossmer CMP-aktivierte fluoreszierende Sialinsäuren sowie Verfahren zu ihrer Herstellung
WO1991016449A1 (en) * 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
CU22302A1 (es) * 1990-09-07 1995-01-31 Cigb Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales
US5352670A (en) * 1991-06-10 1994-10-04 Alberta Research Council Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
KR950014915B1 (ko) * 1991-06-19 1995-12-18 주식회사녹십자 탈시알로당단백-포함화합물
FI100051B (fi) * 1992-02-18 1997-09-15 Favorit Oy Kompostori
US6037452A (en) * 1992-04-10 2000-03-14 Alpha Therapeutic Corporation Poly(alkylene oxide)-Factor VIII or Factor IX conjugate
US5614184A (en) * 1992-07-28 1997-03-25 New England Deaconess Hospital Recombinant human erythropoietin mutants and therapeutic methods employing them
JP3979678B2 (ja) * 1992-08-24 2007-09-19 サントリー株式会社 新規糖転移酵素及びそれをコードする遺伝子並びに該酵素の製造方法
US5374541A (en) * 1993-05-04 1994-12-20 The Scripps Research Institute Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
JPH09501044A (ja) * 1993-05-14 1997-02-04 ジ・アップジョン・カンパニー ＵＤＰ−ＧＡＬＮＡｃ：ポリペプチド、Ｎ−アセチルガラクトサミニルトランスフェラーゼをコードするクローン化されたＤＮＡ
US5621039A (en) * 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
US5443953A (en) * 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
US5369017A (en) * 1994-02-04 1994-11-29 The Scripps Research Institute Process for solid phase glycopeptide synthesis
US5492841A (en) * 1994-02-18 1996-02-20 E. I. Du Pont De Nemours And Company Quaternary ammonium immunogenic conjugates and immunoassay reagents
US5432059A (en) * 1994-04-01 1995-07-11 Specialty Laboratories, Inc. Assay for glycosylation deficiency disorders
US5646113A (en) * 1994-04-07 1997-07-08 Genentech, Inc. Treatment of partial growth hormone insensitivity syndrome
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5834251A (en) * 1994-12-30 1998-11-10 Alko Group Ltd. Methods of modifying carbohydrate moieties
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5728554A (en) * 1995-04-11 1998-03-17 Cytel Corporation Enzymatic synthesis of glycosidic linkages
US6030815A (en) * 1995-04-11 2000-02-29 Neose Technologies, Inc. Enzymatic synthesis of oligosaccharides
US5876980A (en) * 1995-04-11 1999-03-02 Cytel Corporation Enzymatic synthesis of oligosaccharides
US5922577A (en) * 1995-04-11 1999-07-13 Cytel Corporation Enzymatic synthesis of glycosidic linkages
US6015555A (en) * 1995-05-19 2000-01-18 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
AU718439B2 (en) * 1995-09-21 2000-04-13 Genentech Inc. Human growth hormone variants
US5716812A (en) * 1995-12-12 1998-02-10 The University Of British Columbia Methods and compositions for synthesis of oligosaccharides, and the products formed thereby
EP0964690B1 (de) * 1996-10-15 2003-07-09 The Liposome Company, Inc. Peptid-lipid konjugate, liposomen und liposomale arzneimittelverabreichung
US5945314A (en) * 1997-03-31 1999-08-31 Abbott Laboratories Process for synthesizing oligosaccharides
US6183738B1 (en) * 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
US20030027257A1 (en) * 1997-08-21 2003-02-06 University Technologies International, Inc. Sequences for improving the efficiency of secretion of non-secreted protein from mammalian and insect cells
WO1999028491A1 (en) * 1997-12-01 1999-06-10 Cytel Corporation Enzymatic synthesis of gangliosides
EP0924298A1 (de) * 1997-12-18 1999-06-23 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Proteinexpression in Baculovirus-vektor Expressionsystemen
US6362254B2 (en) * 1998-03-12 2002-03-26 Shearwater Corporation Poly(ethylene glycol) derivatives with proximal reactive groups
DE19852729A1 (de) * 1998-11-16 2000-05-18 Werner Reutter Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
US6261805B1 (en) * 1999-07-15 2001-07-17 Boyce Thompson Institute For Plant Research, Inc. Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
US6642038B1 (en) * 1999-09-14 2003-11-04 Genzyme Glycobiology Research Institute, Inc. GlcNAc phosphotransferase of the lysosomal targeting pathway
JP3967594B2 (ja) * 2000-05-15 2007-08-29 エフ．ホフマン−ラ ロシュ アーゲー 新しい薬剤組成物
ATE440959T1 (de) * 2000-06-28 2009-09-15 Glycofi Inc Verfahren für die herstellung modifizierter glykoproteine
US6531121B2 (en) * 2000-12-29 2003-03-11 The Kenneth S. Warren Institute, Inc. Protection and enhancement of erythropoietin-responsive cells, tissues and organs
CA2445494A1 (en) * 2001-05-11 2002-11-21 Aradigm Corporation Optimization of the molecular properties and formulation of proteins delivered by inhalation
US7125843B2 (en) * 2001-10-19 2006-10-24 Neose Technologies, Inc. Glycoconjugates including more than one peptide
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7795210B2 (en) * 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
EP2042196B1 (de) * 2001-10-10 2016-07-13 ratiopharm GmbH Neumodellierung und Glykokonjugation von Granulozyten-Kolonie stimulierender Faktor (G-CSF)
US7696163B2 (en) * 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
AU2002351197A1 (en) * 2001-11-28 2003-06-10 Neose Technologies, Inc. Glycopeptide remodeling using amidases
US20040136955A1 (en) * 2002-09-05 2004-07-15 Barker Nicholas P Modified asialo-interferons and uses thereof
US7405198B2 (en) * 2003-11-24 2008-07-29 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) * 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080015142A1 (en) * 2003-12-03 2008-01-17 Defrees Shawn Glycopegylated Follicle Stimulating Hormone
US7338933B2 (en) * 2004-01-08 2008-03-04 Neose Technologies, Inc. O-linked glycosylation of peptides
US20060024286A1 (en) * 2004-08-02 2006-02-02 Paul Glidden Variants of tRNA synthetase fragments and uses thereof
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides

Also Published As

Publication number Publication date
JP3756182B2 (ja) 2006-03-15
AU3685695A (en) 1996-04-19
US5545553A (en) 1996-08-13
KR100465892B1 (ko) 2005-07-18
US20020127682A1 (en) 2002-09-12
US20050271690A1 (en) 2005-12-08
US5798233A (en) 1998-08-25
EP0784688A1 (de) 1997-07-23
CA2200973A1 (en) 1996-04-04
US20040043464A1 (en) 2004-03-04
JPH10509301A (ja) 1998-09-14
CA2502785A1 (en) 1996-04-04
ES2371440T3 (es) 2012-01-02
US5945322A (en) 1999-08-31
KR970706400A (ko) 1997-11-03
JP2005296022A (ja) 2005-10-27
MX9702351A (es) 1997-10-31
US20100316675A1 (en) 2010-12-16
US6342382B1 (en) 2002-01-29
JP3976765B2 (ja) 2007-09-19
WO1996010086A1 (en) 1996-04-04
DE69535975D1 (de) 2009-08-13
EP0784688B1 (de) 2009-07-01
CA2502785C (en) 2011-05-17
EP1568777A1 (de) 2005-08-31
ATE513916T1 (de) 2011-07-15
US5705367A (en) 1998-01-06
EP1568777B1 (de) 2011-06-22
US8268596B2 (en) 2012-09-18
AU714684B2 (en) 2000-01-06
US6780624B2 (en) 2004-08-24

Similar Documents

Publication Publication Date Title
DE69535975D1 (de) Glycosyltransferasen für die biosynthese von oligosacchariden und dafür kodierende gene
Na et al. Recent progress in synthesis of carbohydrates with sugar nucleotide-dependent glycosyltransferases
Audry et al. Current trends in the structure–activity relationships of sialyltransferases
Palcic Glycosyltransferases as biocatalysts
US5246840A (en) Method for synthesis of oligosaccharides
Kapitonov et al. Conserved domains of glycosyltransferases
DE60028541D1 (de) Campylobacter glycolsyltransferasen zur verwendung bei der biosynthese von gangliosiden und ganglioside imitatoren
McArthur et al. Glycosyltransferase engineering for carbohydrate synthesis
Zervosen et al. A novel three-enzyme reaction cycle for the synthesis of N-acetyllactosamine with in situ regeneration of uridine 5 ‘-diphosphate glucose and uridine 5 ‘-diphosphate galactose
US5374541A (en) Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
Ramakrishnan et al. Structure and catalytic cycle of β-1, 4-galactosyltransferase
Seibel et al. Glycosylation with activated sugars using glycosyltransferases and transglycosidases
Leemhuis et al. Glycosidic bond specificity of glucansucrases: on the role of acceptor substrate binding residues
MXPA00005376A (es) Sintesis enzimatica de gangliosidos.
Pallister et al. Enzyme promiscuity of carbohydrate active enzymes and their applications in biocatalysis
EP0905232A4 (de) Neue beta 1-4 n-acetylglucosaminyltransferase sowie das für diese kodierende gen
WO1994026906A3 (en) Cloned dna encoding a udp-galnac:polypeptide,n-acetylgalactos aminyltransferase
EP1914302A3 (de) Campylobacter-Glycosyltranferasen für die Biosynthese von Gangliosiden und Gangliosid-Nachahmern
Henrissat et al. Glycosyltransferases, glycoside hydrolases: surprise, surprise!
Harduin-Lepers The vertebrate sialylation machinery: structure-function and molecular evolution of GT-29 sialyltransferases
Na et al. Engineer P. multocida heparosan synthase 2 (PmHS2) for size-controlled synthesis of longer heparosan oligosaccharides
Kitazume et al. Developmental expression of trout egg polysialoglycoproteins and the prerequisite alpha 2, 6-, and alpha 2, 8-sialyl and alpha 2, 8-polysialyltransferase activities required for their synthesis during oogenesis.
Namdjou et al. A β‐1, 4‐Galactosyltransferase from Helicobacter pylori is an Efficient and Versatile Biocatalyst Displaying a Novel Activity for Thioglycoside Synthesis
Tseng et al. Exploring regioselective fucosylation catalyzed by bacterial glycosyltransferases through substrate promiscuity and acceptor-mediated glycosylation
Li et al. Glycosyltransferases in human milk oligosaccharide synthesis: structural mechanisms and rational design

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties